Parsons CG - Search Results

1

Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.

Parsons CG, Herz A. Parsons CG, et al. J Pharmacol Exp Ther. 1990 Nov;255(2):795-802. J Pharmacol Exp Ther. 1990. PMID: 2173759

2

Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis.

Parsons CG, Członkowski A, Stein C, Herz A. Parsons CG, et al. Pain. 1990 Apr;41(1):81-93. doi: 10.1016/0304-3959(90)91112-V. Pain. 1990. PMID: 2162022

3

Local opioid receptors mediating antinociception in inflammation: endogenous ligands.

Stein C, Gramsch C, Hassan AH, Przewlocki R, Parsons CG, Peter K, Herz A. Stein C, et al. Among authors: parsons cg. Prog Clin Biol Res. 1990;328:425-7. Prog Clin Biol Res. 1990. PMID: 1968271 No abstract available.

4

Memantine: Updating a rare success story in pro-cognitive therapeutics.

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G. Karimi Tari P, et al. Among authors: parsons cg. Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11. Neuropharmacology. 2024. PMID: 37832633 Free article. Review.

5

Inhalational Anesthetics Do Not Deteriorate Amyloid-β-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.

Hofmann C, Sander A, Wang XX, Buerge M, Jungwirth B, Borgstedt L, Kreuzer M, Kopp C, Schorpp K, Hadian K, Wotjak CT, Ebert T, Ruitenberg M, Parsons CG, Rammes G. Hofmann C, et al. Among authors: parsons cg. J Alzheimers Dis. 2021;84(3):1193-1218. doi: 10.3233/JAD-201185. J Alzheimers Dis. 2021. PMID: 34657881

6

The Aβ aggregation modulator MRZ-99030 prevents and even reverses synaptotoxic effects of Aβ_1-42 on LTP even following serial dilution to a 500:1 stoichiometric excess of Aβ_1-42, suggesting a beneficial prion-like seeding mechanism.

Rammes G, Parsons CG. Rammes G, et al. Among authors: parsons cg. Neuropharmacology. 2020 Nov 15;179:108267. doi: 10.1016/j.neuropharm.2020.108267. Epub 2020 Aug 3. Neuropharmacology. 2020. PMID: 32758564

7

The anaesthetic xenon partially restores an amyloid beta-induced impairment in murine hippocampal synaptic plasticity.

Bürge M, Kratzer S, Mattusch C, Hofmann C, Kreuzer M, Parsons CG, Rammes G. Bürge M, et al. Among authors: parsons cg. Neuropharmacology. 2019 Jun;151:21-32. doi: 10.1016/j.neuropharm.2019.03.031. Epub 2019 Mar 30. Neuropharmacology. 2019. PMID: 30940537

8

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.

Parsons CG. Parsons CG. Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27. Neuropharmacology. 2019. PMID: 30165077 Review.

9

The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).

Rammes G, Seeser F, Mattusch K, Zhu K, Haas L, Kummer M, Heneka M, Herms J, Parsons CG. Rammes G, et al. Among authors: parsons cg. Neuropharmacology. 2018 Sep 15;140:184-192. doi: 10.1016/j.neuropharm.2018.07.021. Epub 2018 Aug 11. Neuropharmacology. 2018. PMID: 30016667

10

Preclinical to phase II amyloid beta (A_β) peptide modulators under investigation for Alzheimer's disease.

Parsons CG, Rammes G. Parsons CG, et al. Expert Opin Investig Drugs. 2017 May;26(5):579-592. doi: 10.1080/13543784.2017.1313832. Expert Opin Investig Drugs. 2017. PMID: 28362514 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page